Actual questions of treatment of urinary tract infection in neonates
Abstract
The aim of this study was to evaluate the structure of etiotropic therapy used in the treatment of urinary tract infection in newborns, the frequency of using off-label etiotropic medicines, and assess the incidence of adverse drugs reactions (ADR). The work was carried out by a retrospective pharmacoepidemiology analysis of children hospitalized patient history (form 003/y) with infectious diseases in the period of the newborn. The object of the study is a case history of a stationary patient, the main method of research is the collection and analysis of information, the statistical processing of the data obtained. During the analysis, all the selected medical records were divided into two groups: the first - children, with the course of urinary tract infection, the second - with the course of infectious diseases of other localization. During the study it was demonstrated that the use of etiotropic therapy in children with urinary infection is higher than in children with the course of the infectious process of other localization. The frequency of off-label prescriptions for the treatment of urinary tract infection is 51%, and the incidence of ADR in the case of unadapted appointments is 1,4 times higher.
About the Authors
S. K. Zyryanov
Peoples' Friendship University of Russia, Moscow, Russia
Russian Federation
Russian Federation
O. A. Shulakova
Russian University of Nations’ Friendship
Russian Federation
Russian Federation
K. G. Gurevich
Moscow State University of Medicine and Dentistry named after A.I. Evdokimov
Russian Federation
Russian Federation
References
1. Баранов А.А., Альбицкий В.Ю., Устинова Н.В. Состояние, проблемы и перспективы организации медико-социальной помощи детям. Российский педиатрический журнал. 2013; 3: 4-6.
2. Conroy S., Choonara I., Imgicciatore P. Sur very of unlicensed and off label drug use in pediatric wards in European countries. BMJ 2000; 320: 79-82.
3. O’Donnell C.P., Stone R.J., Morley C.J. Unlicensed and off label drug use in an Australian nejnatal intensive care unit. Pediatrics 2002: 110-52.
4. McInture J., Conroy S., Choonara I. Unlicensed and off label drug use in neonates. Arc Dis Child Fetal Neonatal Ed 2003; 80: 142-145.
5. Зырянов С.К., Белоусов Ю.Б. Использование лекарств в педиатрии: есть ли проблемы? Медицинские технологии. Оценка и выбор 2011; 2: 37-41.
6. Рачина С.А., Белохвостова А.С., Жаркова Л.П. Распространенность применения unlicensed и offlabel лекарственных средств в педиатрической практике г. Смоленска. Педиатрическая фармакология 2010; 4: 7: 56-60.
7. Колбин А.С. Клинико-экономические и фармакоэпидемиологические аспекты противогрибковых средств у детей с инвазивным микозом: автореф. дис.. докт.мед.наук: 14.00.25, Санкт-Петербург, 2006.
8. Белоусов Ю.Б., Кукес В.Г., Лепахин В.К. и др. Клиническая фармакология: национальное руководство. М.: ГЭОТАР=Медиа, 2009; 257-280.
9. Temple M.E., Robinson R.F., Miller J.C. Frequency and Preventability of Adverse Drug Reactions in Paediatric Patients. Drug Safety 2004; 28 (11): 819-829.
10. Horen B., Montastruc J.L., Lapeyre-mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br. J. Clin. Pharmacol 2002 Dec; 54 (6): 665-670.
11. Титова А.Р., Асецкая И.Л., Зырянов С.К., Поливанов В.А. Нерегламентированное (off-label) применение лекарственных препаратов в педиатрической практике: нерешенные проблемы. Педиатрическая фармакология 2015; 12 (3): 304-308.
12. Çoban B., Ülkü N., Kaplan H., Topal B. Five-year assessment of causative agents and antibiotic resistances in urinary tract infections. Turk Pediatr Ars 2014, Jun; 149 (2): 124-129.
13. Liu X., Wang Y., Shao F Sepsis in a newborn with anterior urethral valve and urinary tract infection. Chin Med J (Engl) 2014; 127 (2): 399-400.
14. Bonadio W., Maida G. Urinary tract infection in outpatient febrile infants younger than 30 days of age: a 10-year evaluation.Pediatr Infect Dis J 2014 Apr; 33 (4): 342-344.
15. Segger J.D., Kong S.X., SHumock G.T., Segger J.D. Characteristics Associated with Ability to Prevent Adverse Drug Reactions in Hospitalized Patients. Pharmacotherapy 1998; 18 (6): 1284-1289.
Review
For citations:
Zyryanov S.K., Shulakova O.A., Gurevich K.G. Actual questions of treatment of urinary tract infection in neonates. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2017;(1):46-50. (In Russ.)
Views:
1010
Email this article 